Abstract
Objectives
To investigate the usefulness of the criteria with liver stiffness (LS) measured by two-dimensional shear wave elastography (2D-SWE) and platelet count (PLT) for ruling out high-risk varices in patients with compensated advanced chronic liver disease (cACLD).
Methods
A total of 661 patients with cACLD had successfully undergone 2D-SWE and endoscopy screening. We analyzed risk factors for the presence of high-risk varices and compared proportions of patients who were spared endoscopy when used the predicting criteria with LS (ranged from 16 to 25 kPa) and PLT (ranged from 80 × 109/L to 150 × 109/L).
Results
PLT, albumin, LS were found to be independent predictors of high-risk varices. The LS values for ruling out and ruling in high-risk varices were 14.0 kPa and 24.8 kPa, respectively. When the Baveno VI criteria LS < 20 kPa and PLT > 150 × 109/L were used, the high-risk varices miss rate was 2.1%, while the saved endoscopy rate only was 19.2%. The new criteria that LS < 16 kPa and PLT > 100 × 109/L saved 30.4–34.6% endoscopy with 0–3.2% high-risk varices miss rate in the subgroup analysis stratified according to the types of underlying liver disease.
Conclusions
The Baveno VI criteria can be applied to LS measurement by 2D-SWE. The new criteria that LS < 16 kPa and PLT > 100 × 109/L could be a potential model to spare more endoscopy screening with < 5% high-risk varices miss rate.
Key Points
• LS measured by 2D-SWE is reliable predictive factor for predicting all-size varices and high-risk varices in patients with compensated advanced chronic liver disease.
• LS measured by 2D-SWE < 16 kPa and PLT > 100 × 109 /L, which can spare more endoscopy than Baveno VI criteria with < 5% high-risk varices miss rate.
• The Baveno VI criteria can be applied to LS measurement by 2D-SWE.
Similar content being viewed by others
Change history
01 February 2024
A Correction to this paper has been published: https://doi.org/10.1007/s00330-023-10577-4
Abbreviations
- 2D-SWE:
-
Two-dimensional shear wave elastography
- AIH:
-
Autoimmune liver disease
- ALT:
-
Alanine aminotransferase
- AST:
-
Aspartate aminotransferase
- AUROC:
-
Areas under receiver operating characteristic curve
- cACLD:
-
Compensated advanced chronic liver disease
- CI:
-
Confidence index
- CSPH:
-
Clinically significant portal hypertension
- HVPG:
-
Hepatic venous pressure gradient
- INR:
-
International normalized ratio
- LS:
-
Liver stiffness
- MELD:
-
Model for end-stage liver disease
- NPV:
-
Negative predictive value
- PBC:
-
Primary biliary cholangitis
- PLT:
-
Platelet count
- PPV:
-
Positive predictive value
- PT:
-
Prothrombin time
- TE:
-
Transient elastography
References
Kim HY, So YH, Kim W et al (2019) Non-invasive response prediction in prophylactic carvedilol therapy for cirrhotic patients with esophageal varices. J Hepatol 70:412–422
de Franchis R, Baveno VIF (2015) Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol 63:743–752
Stafylidou M, Paschos P, Katsoula A et al (2019) Performance of Baveno VI and expanded Baveno VI criteria for excluding high-risk varices in patients with chronic liver diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 17:1744-1755 e1711
Colecchia A, Ravaioli F, Marasco G et al (2018) A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease. J Hepatol 69:308–317
Wong GLH, Liang LY, Kwok R et al (2019) Low risk of variceal bleeding in patients with cirrhosis after variceal screening stratified by liver/spleen stiffness. Hepatology 70:971–981
Thabut D, Bureau C, Layese R et al (2019) Validation of Baveno VI criteria for screening and surveillance of esophageal varices in patients with compensated cirrhosis and a sustained response to antiviral therapy. Gastroenterology 156:997-1009 e1005
Moctezuma-Velazquez C, Saffioti F, Tasayco-Huaman S et al (2019) Non-invasive prediction of high-risk varices in patients with primary biliary cholangitis and primary sclerosing cholangitis. Am J Gastroenterol 114:446–452
Berger A, Ravaioli F, Farcau O et al (2020) Including ratio of platelets to liver stiffness improves accuracy of screening for esophageal varices that require treatment. Clin Gastroenterol Hepatol. https://doi.org/10.1016/j.cgh.2020.06.022
Castera L, Foucher J, Bernard PH et al (2010) Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology 51:828–835
Gao Y, Zheng J, Liang P et al (2018) Liver fibrosis with two-dimensional US shear-wave elastography in participants with chronic hepatitis B: a prospective multicenter study. Radiology 289:407–415
Elkrief L, Rautou PE, Ronot M et al (2015) Prospective comparison of spleen and liver stiffness by using shear-wave and transient elastography for detection of portal hypertension in cirrhosis. Radiology 275:589–598
Furlan A, Tublin ME, Yu L, Chopra KB, Lippello A, Behari J (2020) Comparison of 2D shear wave elastography, transient elastography, and MR elastography for the diagnosis of fibrosis in patients with nonalcoholic fatty liver disease. AJR Am J Roentgenol 214:W20–W26
Thiele M, Hugger MB, Kim Y et al (2020) 2D shear wave liver elastography by aixplorer to detect portal hypertension in cirrhosis: an individual patient data meta-analysis. Liver Int 40:1435–1446
Jansen C, Bogs C, Krag A, Francque S, Trebicka J (2017) Sequential shear-wave elastography of liver and spleen rules out clinically significant portal hypertension in compensated advanced chronic liver disease. Gut 66:558–559
Elkrief L, Ronot M, Andrade F et al (2018) Non-invasive evaluation of portal hypertension using shear-wave elastography: analysis of two algorithms combining liver and spleen stiffness in 191 patients with cirrhosis. Aliment Pharmacol Ther 47:621–630
Kim TY, Kim TY, Kim Y, Lim S, Jeong WK, Sohn JH (2016) Diagnostic performance of shear wave elastography for predicting esophageal varices in patients with compensated liver cirrhosis. J Ultrasound Med 35:1373–1381
Yoo HW, Kim YS, Kim SG et al (2019) Usefulness of noninvasive methods including assessment of liver stiffness by 2-dimensional shear wave elastography for predicting esophageal varices. Dig Liver Dis 51:1706–1712
Petzold G, Tsaknakis B, Bremer SCB et al (2019) Evaluation of liver stiffness by 2D-SWE in combination with non-invasive parameters as predictors for esophageal varices in patients with advanced chronic liver disease. Scand J Gastroenterol 54:342–349
European Association for the Study of the Liver (2021) Easl clinical practice guidelines (Cpgs) on non-invasive tests for evaluation of liver disease severity and prognosis-2020 Update. J Hepatol. https://doi.org/10.1016/j.jhep.2021.05.025
Cassinotto C, Lapuyade B, Guiu B et al (2020) Agreement between 2-dimensional shear wave and transient elastography values for diagnosis of advanced chronic liver disease. Clin Gastroenterol Hepatol. https://doi.org/10.1016/j.cgh.2020.04.034
Herrmann E, de Ledinghen V, Cassinotto C et al (2018) Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: an individual patient data-based meta-analysis. Hepatology 67:260–272
Grgurevic I, Puljiz Z, Brnic D et al (2015) Liver and spleen stiffness and their ratio assessed by real-time two dimensional-shear wave elastography in patients with liver fibrosis and cirrhosis due to chronic viral hepatitis. Eur Radiol 25:3214–3221
Furlan A, Tublin ME, Yu L, Chopra KB, Lippello A, Behari J (2020) Comparison of 2D shear wave elastography, transient elastography, and mr elastography for the diagnosis of fibrosis in patients with nonalcoholic fatty liver disease. AJR Am J Roentgenol 214:W20–W26
Zeng J, Zheng J, Huang ZP et al (2017) Comparison of 2-D shear wave elastography and transient elastography for assessing liver fibrosis in chronic hepatitis B. Ultrasound Med Biol 43:1563–1570
Ferraioli G, Wong VW, Castera L et al (2018) Liver ultrasound elastography: an update to the world federation for ultrasound in medicine and biology guidelines and recommendations. Ultrasound Med Biol 44:2419–2440
Wang CZ, Zheng J, Huang ZP et al (2014) Influence of measurement depth on the stiffness assessment of healthy liver with real-time shear wave elastography. Ultrasound Med Biol 40:461–469
Calvaruso V, Cacciola I, Licata A et al (2019) Is transient elastography needed for noninvasive assessment of high-risk varices? The REAL Experience. Am J Gastroenterol 114:1275–1282
Kew GS, Chen ZJ, Yip AW et al (2021) Identifying patients with cirrhosis who might avoid screening endoscopy based on serum albumin and bilirubin and platelet counts. Clin Gastroenterol Hepatol 19:199
Yu JB, Xiong H, Yuan XC, Zhou AY (2019) Liver stiffness detected by shear wave elastography predicts esophageal varices in cirrhotic patients. Ultrasound Q. https://doi.org/10.1097/RUQ.0000000000000466
Kang SH, Baik SK, Kim MY (2020) Application of Baveno criteria and modified baveno criteria with shear-wave elastography in compensated advanced chronic liver disease. J Korean Med Sci 35:e249
Cho YS, Kim Y, Sohn JH (2020) Application of supersonic shear imaging to the Baveno VI criteria and a combination model with spleen stiffness measurement to rule out high-risk varices in compensated advanced chronic liver disease. Ultraschall Med. https://doi.org/10.1055/a-1168-6271
Suh CH, Kim KW, Park SH et al (2018) Shear wave elastography as a quantitative biomarker of clinically significant portal hypertension: a systematic review and meta-analysis. AJR Am J Roentgenol 210:W185–W195
Gaete MI, Diaz LA, Arenas A et al (2020) Baveno VI and expanded Baveno VI criteria successfully predicts the absence of high-risk gastro-oesophageal varices in a Chilean cohort. Liver Int 40:1427–1434
Petta S, Sebastiani G, Bugianesi E et al (2018) Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis. J Hepatol 69:878–885
Augustin S, Pons M, Maurice JB et al (2017) Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease. Hepatology 66:1980–1988
Wang H, Wen B, Chang X et al (2021) Baveno VI criteria and spleen stiffness measurement rule out high-risk varices in virally suppressed HBV-related cirrhosis. J Hepatol 74:584–592
Berger A, Ravaioli F, Farcau O et al (2021) Including ratio of platelets to liver stiffness improves accuracy of screening for esophageal varices that require treatment. Clin Gastroenterol Hepatol 19:777-787 e717
Ikeda F, Okamoto R, Baba N et al (2012) Prevalence and associated factors with esophageal varices in early primary biliary cirrhosis. J Gastroenterol Hepatol 27:1320–1328
Ali AH, Sinakos E, Silveira MG, Jorgensen RA, Angulo P, Lindor KD (2011) Varices in early histological stage primary biliary cirrhosis. J Clin Gastroenterol 45:e66-71
Lee HA, Kim SU, Seo YS et al (2019) Prediction of the varices needing treatment with non-invasive tests in patients with compensated advanced chronic liver disease. Liver Int 39:1071–1079
Kew G, Chen Z, Yip A et al (2021) Identifying patients with cirrhosis who might avoid screening endoscopy based on serum albumin and bilirubin and platelet counts. Clin Gastroenterol Hepatol 19:199-201.e192
Dong T, Kalani A, Aby E et al (2019) Machine learning-based development and validation of a scoring system for screening high-risk esophageal varices. Clin Gastroenterol Hepatol 17:1894-1901.e1891
Kotwal V, Mbachi C, Wang Y et al (2020) A novel score to predict esophageal varices in patients with compensated advanced chronic liver disease. Dig Dis Sci. https://doi.org/10.1007/s10620-020-06456-3
Jangouk P, Turco L, De Oliveira A, Schepis F, Villa E, Garcia-Tsao G (2017) Validating, deconstructing and refining Baveno criteria for ruling out high-risk varices in patients with compensated cirrhosis. Liver Int 37:1177–1183
Funding
This study has received funding: Post-Doctor Research Project, West China Hospital, Sichuan University (No. 2019HXBH045) and China Postdoctoral Science Foundation (No. 2020M673263).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor of this publication is Li Yang.
Conflict of interest
The authors declare no competing interests.
Statistics and biometry
No complex statistical methods were necessary for this paper.
Informed consent
Written informed consent was waived by the institutional review board.
Ethical approval
Institutional review board approval was obtained.
Methodology
• retrospective.
• diagnostic and prognostic study.
• performed at one institution.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original online version of this article was revised: Some results in Table 3 Section "High-risk varices" row "Rule in" were incorrect. The correct Table 3 is as follows. The revised entries have been emphasized for purposes of clarity: Rule in24.836.1%95.1%75.0%78.5%78.1%
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Yan, Y., Xing, X., Wang, X. et al. Liver stiffness by two-dimensional shear wave elastography for screening high-risk varices in patients with compensated advanced chronic liver disease. Eur Radiol 32, 2078–2088 (2022). https://doi.org/10.1007/s00330-021-08280-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-021-08280-3